Efficacy and economics of targeted panel versus whole exome sequencing in 878 patients with suspected primary immunodeficiency

BACKGROUND: NGS has become a first-line tool for diagnosis of PID. However, patient access remains limited due to restricted insurance coverage and a lack of guidelines addressing use of targeted panels vs WES. OBJECTIVES: To compare targeted next generation sequencing (NGS) with whole exome sequenc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Allergy Clin Immunol
Main Authors: Platt, Craig D., Zaman, Fatima, Bainter, Wayne, Stafstrom, Kelsey, Almutairi, Abuarahman, Reigle, Margot, Weeks, Sabrina, Geha, Raif S., Janet, Chou
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7870529/
https://ncbi.nlm.nih.gov/pubmed/32888943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2020.08.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados